Editorial - (2020) Volume 8, Issue 2
Srikanth Boinapally*
Johns Hopkins University, USA
Receipt date: 20-04-2020; Revision date: 23-04-2020; Acceptance date: 30-04-2020
American Journal of Advanced Drug Delivery (IPAAD) has become multidisciplinary in nature and yielding a great benefit to the medical community and the society. The Journal is having wide indexing in: NLM ID: 101731920; Google Scholar, ICMJE, SHEPRA/ROMEO, Genamics, International Society of Universal Research in Sciences, academia.edu, Pak Directory of Open Access Journals, Research Bible, Scientific Journal Impact Factor, Open Academic Journal Index, Jour Informatics, Index Copernicus, Cite SeerX, Gold Rush and Global Impact Factor.
Planning and development of journal in the year 2020 include various activities such as high Social media marketing that can play a key role in spreading research work globally with increased visibility, citation. We promote published articles to the social media platforms via Twitter; Facebook; Linkedin; etc. We are also committed to focus on various secondary and sub classes of Botanical Sciences, that will provide keen insights of the field.
The present Global Impact and Quality Factor of American Journal of Advanced Drug Delivery is 0.786. IPAAD press releases in the year 2019 provided information, an official statement, or making an announcement.
IPAAD welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence such as Drug Discovery, Drug Targeting, Protein/peptide delivery, Drug Design, Drug Delivery Systems, Drug Design and Development, Controlledrelease systems, Sustain release systems etc. IPAAD in the upcoming issue in the year 2020 will be dealing with the new innovative practices as well the study in the respective fields.
We have been with “n” number of scientists, supporting their works and their efforts and held an important role of spreading the newer information and advancements to the community since 8 years by publishing an issue once in every two months which constitutes at-least 32 issues till 2019 an now we have entered our eighth volume and released two issues with high quality research papers.
We are one of the biggest open access publication networks available in the world that handles social media sites to publicize the articles published by our journals in order to introduce new information about the recent research works and getting talented researchers in to the lime light. We encourage our blogger to draw the interest of reader towards the research and for providing an acknowledgement about the ongoing researches and serving the purpose of academics.
We do work on different topics which fall under the stream of advanced drug delivery like:
All delivery systems and modes of entry
Controlled-release systems
Sustain release systems
Microcapsules/microparticles
Liposomes
Vesicles and macromolecular conjugates
Antibody targeting
Protein/peptide delivery
Drug Targeting
More than 2,822,814 users have accessed the publisher website. These stats reveal that the journal is also immensely popular among scientific societies and organizations. Consequently, the editorial board profiles, authors and their affiliations are also gaining higher visibility.
We would like to convey our sincere thanks and regard to all our reviewers, editors and authors who have been working with us through the journey of 10 years with all their interest and willingness towards service towards the scientific society.